MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barabino, B.
Right arrow Articles by Gotti, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barabino, B.
Right arrow Articles by Gotti, C.

Vol. 59, Issue 6, 1410-1417, June 2001

An alpha 4beta 4 Nicotinic Receptor Subtype Is Present in Chick Retina: Identification, Characterization and Pharmacological Comparison with the Transfected alpha 4beta 4 and alpha 6beta 4 Subtypes

Benedetta Barabino, Silvia Vailati, Milena Moretti, J. Michael McIntosh, Renato Longhi, Francesco Clementi, and Cecilia Gotti

Department of Experimental Medicine and Pathology, La Sapienza University, Rome (B.B.); Department of Biochemistry, Science II, University of Geneva, Geneva, Switzerland (B.B.); CNR Cellular and Molecular Pharmacology Center, Department of Medical Pharmacology, University of Milan, Milan, Italy (S.V., M.M., F.C., C.G.); Department of Biology, University of Utah, Salt Lake City, Utah (J.M.M.); and CNR Center for Hormone Chemistry, Milan, Italy (R.L.)

Retina from 1-day-old chicks is a valuable tissue model for studying neuronal nicotinic receptors because it expresses a large number of the developmentally regulated high affinity [3H]epibatidine labeled nicotinic receptors. Most of these receptors contain the beta 4 subunit associated with different alpha  subunits. Using a sequential immunodepletion procedure with anti-alpha 6, anti-beta 3, anti-beta 2, and anti-beta 4 antibodies, we purified an alpha 4beta 4 nicotinic receptor subtype that accounts for approximately 20 to 25% of the high affinity [3H]epibatidine labeled receptors present in retina at that developmental time. Immunoprecipitation and Western blotting experiments confirmed that the purified subtype contains only the alpha 4 and beta 4 subunits. This receptor binds a number of agonists and the antagonist dihydro-beta -erythroidine with nanomolar affinity, whereas it has micromolar affinity for the alpha -conotoxin MII and methyllycaconitine toxins and other nicotinic antagonists. Comparison of the pharmacological profile of this purified native subtype with that of the same subtype transiently expressed in human BOSC23 cells showed that they have very similar rank orders and absolute Ki values for several nicotinic drugs. Finally, because chick retina expresses an alpha 6beta 4-containing subtype with a high affinity for the alpha -conotoxin MII, we used native and transfected alpha 4beta 4 and alpha 6beta 4 subtypes to investigate the relative contributions of the alpha  and beta  subunits to this binding, and found that the alpha 6 subunit determines the high affinity for this toxin.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
C. E. Strang, M. E. Andison, F. R. Amthor, and K. T. Keyser
Rabbit retinal ganglion cells express functional {alpha}7 nicotinic acetylcholine receptors
Am J Physiol Cell Physiol, September 1, 2005; 289(3): C644 - C655.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
V. P. Grinevich, S. R. Letchworth, K. A. Lindenberger, J. Menager, V. Mary, K. A. Sadieva, L. M. Buhlman, G. A. Bohme, L. Pradier, J. Benavides, et al.
Heterologous Expression of Human {alpha}6{beta}4{beta}3{alpha}5 Nicotinic Acetylcholine Receptors: Binding Properties Consistent with Their Natural Expression Require Quaternary Subunit Assembly Including the {alpha}5 Subunit
J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 619 - 626.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Azam and J. M. McIntosh
Effect of Novel {alpha}-Conotoxins on Nicotine-Stimulated [3H]Dopamine Release from Rat Striatal Synaptosomes
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 231 - 237.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Moretti, S. Vailati, M. Zoli, G. Lippi, L. Riganti, R. Longhi, A. Viegi, F. Clementi, and C. Gotti
Nicotinic Acetylcholine Receptor Subtypes Expression during Rat Retina Development and Their Regulation by Visual Experience
Mol. Pharmacol., July 1, 2004; 66(1): 85 - 96.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Vailati, M. Moretti, R. Longhi, G. E. Rovati, F. Clementi, and C. Gotti
Developmental Expression of Heteromeric Nicotinic Receptor Subtypes in Chick Retina
Mol. Pharmacol., June 1, 2003; 63(6): 1329 - 1337.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Zoli, M. Moretti, A. Zanardi, J. M. McIntosh, F. Clementi, and C. Gotti
Identification of the Nicotinic Receptor Subtypes Expressed on Dopaminergic Terminals in the Rat Striatum
J. Neurosci., October 15, 2002; 22(20): 8785 - 8789.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics